GABA/A receptors are a major target for ethanol in the brain. Chronic ethanol administration alters many aspects of GABA function in animals. Similarly, post-mortem human studies documented reductions in the density of binding to the benzodiazepine (BZ) site of the GABA/A receptor. Until recently, clinical studies were limited to GABA measurements in blood and cerebrospinal fluid (CSF). These studies suggest that GABA levels are normal in alcohol dependent patients, decline among the first month of sobriety, and recover within 6 months of their last drink. Recent neuroimaging advances now make it possible to measure aspects of GABA function in the human brain in vivo. Our group has advanced the quantification of regional GABA levels in the human cerebral cortex using 1H-magnetic resonance spectroscopy (1H-NMR). Using this technique, our pilot data indicate that GABA levels in the occipital cortex are reduced in male early onset alcoholic patients sober for 1 month relative to a matched group of healthy subjects. We have also contributed to the development of a single photon emission computerized tomography computerized tomography (SPECT) technique, employing [123I]-iomazenil, for assessing a measure, Vt, a measure related to the density of binding to BZ receptors. Employing this technique, we found reductions in frontal and occipital cortex BZ receptor binding from a similar group of recently detoxified alcoholic patients. The principal objective of this proposal is to provide the first longitudinal description of the recovery of brain GABA systems with sobriety in alcohol dependent alcoholic patients. Patients (n=50) would be assessed using both 1H-NMR and SPECT at 3 timepoints in relation to their last drink (,7 days, 1 month, 6 months). The first two assessments (,7 days, 1 month) would be completed as inpatients to insure sobriety. Results from patients would be compared to a matched healthy control group (n=25) studied at similar intervals. Both 1H-NMR and SPECT data would be segmented into components arising from gray matter, white matter, and CSF, providing a correction for gray matter atrophy. Further, metabolites measured simultaneously with GABA during 1H- NMR imaging, such as N-acetylaspartate and creatine, will provide additional information about cortical neuronal viability. Thus, this proposal would provide a multi-dimensional evaluation of GABA disturbances that may help to clarify both the pharmacologic and neurotoxic consequences of alcoholism.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
1R01AA011321-01A2
Application #
2765757
Study Section
Special Emphasis Panel (ZRG4-ALTX-3 (01))
Program Officer
Witt, Ellen
Project Start
1999-02-01
Project End
2004-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Cosgrove, Kelly P; McKay, Reese; Esterlis, Irina et al. (2014) Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal. Proc Natl Acad Sci U S A 111:18031-6
Nestler, Eric J; Krystal, John H (2012) Planning the new national institute on substance use and addiction disorders. Biol Psychiatry 72:166-7
Gomez, Rosane; Behar, Kevin L; Watzl, June et al. (2012) Intravenous ethanol infusion decreases human cortical ?-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biol Psychiatry 71:239-46
Freeman, Willard M; Vanguilder, Heather D; Guidone, Elizabeth et al. (2011) Plasma proteomic alterations in non-human primates and humans after chronic alcohol self-administration. Int J Neuropsychopharmacol 14:899-911
Gueorguieva, Ralitza; Wu, Ran; Donovan, Dennis et al. (2011) Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study. Alcohol Clin Exp Res 35:523-31
Krystal, John H; Mathew, Sanjay J; D'Souza, D Cyril et al. (2010) Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 24:669-93
Patel, Anant B; de Graaf, Robin A; Rothman, Douglas L et al. (2010) Evaluation of cerebral acetate transport and metabolic rates in the rat brain in vivo using 1H-[13C]-NMR. J Cereb Blood Flow Metab 30:1200-13
Urban, Nina B L; Kegeles, Lawrence S; Slifstein, Mark et al. (2010) Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride. Biol Psychiatry 68:689-96
Gueorguieva, Ralitza; Wu, Ran; Donovan, Dennis et al. (2010) Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug Alcohol Depend 107:221-9
Watson, Todd D; Petrakis, Ismene L; Edgecombe, Javon et al. (2009) Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission. Int J Neuropsychopharmacol 12:357-70

Showing the most recent 10 out of 25 publications